NCT06764121

Impact of Canadian Haskap Berry Powder on Hypertension and Acuity in Women's Health

Impact of Haskalife(TM) Canadian Haskap Berry Powder Formulation on Hypertension and Acuity in Women's Health

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: University of Manitoba · Academic / Other
• Sex: Female
• Age: 35 Years
• Healthy volunteers: Not accepted

Summary

Haskap berries are rich in cyanidin-3-O-glucoside (C3G), which has been shown in vitro to enhance endothelial function. Previous clinical studies suggest haskap berry supplementation may improve cognition, mood, blood pressure, and athletic performance, but research is limited. This trial aims to contribute to the growing body of evidence on the effects of haskap berry supplementation. The trial is a 2-period, randomized, double-blinded, cross-over design lasting 16 weeks. During the first period (weeks 0-6), participants will receive either haskap berry powder or a control powder. A 4-week washout period follows (weeks 7-10), where no powder is consumed. In the second period (weeks 11-16), participants will receive the powder they did not consume in the first period.

Conditions

• Hypertension
• Alertness

Interventions

Type	Name	Description
OTHER	Haskap Berry Powder	The participants will consume four packets (16g) of haskap berry powder. The powder can be consumed with other food products.
OTHER	Placebo Powder	The participants will consume four packets (24g) of placebo powder. The powder can be consumed with other food products.

Timeline

• Start date: 2025-04-03
• Primary completion: 2026-03-26
• Completion: 2026-08-06
• First posted: 2025-01-08
• Last updated: 2025-12-04

Locations

1 site across 1 country: Canada